About us
Our expertise
Commercial >
We provide commercial consulting and advisory solutions across the product development and commercialization lifecycle.

Portfolio, Licensing & Development >

Commercialization & Growth >

Data Strategy & Analytics >

Value, Pricing & Access >
Our expertise across scientific and commercial domains delivers a collaborative and bespoke approach to maximize patient access and the commercial success of your innovations.

Value, Pricing & Access Strategy >

HEOR Evidence Generation >

Evidence Synthesis & RWE Generation >

Medical & Scientific Affairs >
We provide world-class thought partnership and solutions that enhance the business impact of medical and scientific affairs.

Asset Development >

Launch Strategy >

Digital Health & Omnichannel Strategy >

Centers of Excellence >
Putnam’s Centers of Excellence allow us to dig deep, challenge convention, and take you further with strategies underpinned by technical expertise in cutting-edge topics.

Advanced Clinical Technologies >

Forecasting & Financial Modeling >

Integrated Insights >
AI at Putnam

A strategic thought partner for your AI journey

Learn more
Join Putnam
Insights

Contact

Latest thinking.

Explore our latest insights and perspectives in these life science resources, news articles, and events.

Topic

Content Type

Recent Trends in Rare Diseases

Putnam experts share observations on recent global trends in the rare disease space and recommend strategies to maximize opportunities.

Key trends driving the emergence of targeted radioth...

Targeted radiopharmaceuticals are transforming cancer treatment and may become the ultimate focal therapy.

Simplify to amplify: “Declutter” your current Custom...

Learn how Putnam reviewed the paths took by five prominent biotech companies to establish itself as a successful commercial-stage organization.

Biotech path archetypes from pre-clinical stage to c...

Learn how Putnam reviewed the paths taken by five prominent biotech companies to establish themselves as successful commercial-stage organizations.

Distributional cost‑effectiveness analysis of treatm...

Putnam aimed to conduct an aggregate DCEA of two NSCLC treatments recommended by NICE, and identify key drivers of the analysis.

The burden of hospitalizations for COVID-19 in Franc...

Our Putnam PHMR colleagues delivered an in-depth analysis on the burden of patient hospitalizations in France as a result of COVID-19.

Unlocking the promise of cell therapies for solid tu...

Our cell and gene therapy experts offer a deep analysis on the current opportunities and challenges of cell therapies for solid tumors.

Get in touch.

Looking to get in touch with an expert or team member?

Tell us how we can help.